Moderna Inc said on Thursday that waiving intellectual property rights on COVID-19 vaccines will not help boost supply in 2021 or 2022, a day after US President Joe Biden backed a proposed waiver that is aimed at giving poorer companies access.
Moderna says waiving IP rights won't help increase vaccine supply
